Your browser doesn't support javascript.
loading
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Iwuji, Collins C; Orne-Gliemann, Joanna; Larmarange, Joseph; Balestre, Eric; Thiebaut, Rodolphe; Tanser, Frank; Okesola, Nonhlanhla; Makowa, Thembisa; Dreyer, Jaco; Herbst, Kobus; McGrath, Nuala; Bärnighausen, Till; Boyer, Sylvie; De Oliveira, Tulio; Rekacewicz, Claire; Bazin, Brigitte; Newell, Marie-Louise; Pillay, Deenan; Dabis, François.
Afiliação
  • Iwuji CC; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; Research Department of Infection and Population Health, University College London, London, UK; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
  • Orne-Gliemann J; University of Bordeaux, ISPED, INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France.
  • Larmarange J; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; Centre Population et Développement (UMR 196 Paris Descartes IRD), SageSud (ERL INSERM 1244), Institut de Recherche pour le Développement, Paris, France.
  • Balestre E; University of Bordeaux, ISPED, INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France.
  • Thiebaut R; University of Bordeaux, ISPED, INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France.
  • Tanser F; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
  • Okesola N; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.
  • Makowa T; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.
  • Dreyer J; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.
  • Herbst K; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.
  • McGrath N; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; Research Department of Epidemiology and Public Health, University College London, London, UK; Academic Unit of Primary Care and Population Sciences and Department of Social Statistics and Demography, University of Southampton, So
  • Bärnighausen T; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; Department of Global Health and Population, Harvard School of Public Health, Harvard University, Boston, MA, USA; Institute of Public Health, Faculty of Medicine, Heidelberg University, Heidelberg, Germany.
  • Boyer S; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.
  • De Oliveira T; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; Nelson R Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
  • Rekacewicz C; Agence Nationale de Recherches sur le Sida et les hépatites virales (ANRS), Paris, France.
  • Bazin B; Agence Nationale de Recherches sur le Sida et les hépatites virales (ANRS), Paris, France.
  • Newell ML; Human Development and Health, Global Health Research Institute, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Pillay D; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa; Division of Infection and Immunity, University College London, London, UK. Electronic address: dpillay@ahri.org.
  • Dabis F; University of Bordeaux, ISPED, INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France. Electronic address: francois.dabis@u-bordeaux.fr.
Lancet HIV ; 5(3): e116-e125, 2018 03.
Article em En | MEDLINE | ID: mdl-29199100
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Benzoxazinas / Tenofovir / Emtricitabina Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Lancet HIV Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Benzoxazinas / Tenofovir / Emtricitabina Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Lancet HIV Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido